Logo
Alterity Therapeutics

American Neurological Association (ANA): ATH434 Preserves Dopaminergic Neurons, Reduces α-synuclein Oligomerization, and Improves Motor Function in a Transgenic Murine Multiple System Atrophy Model

Share your feedback

Discover